Net income
−$15.6M
+37% vs same quarter last year
EPS, diluted
−$0.91
+68.7% vs same quarter last year
Operating cash flow
−$9.5M
+55.7% vs same quarter last year
Operating income
−$17.3M
+33.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $800K | −$45.3M |
| FY24 | $3.5M | −$36.6M |
| FY23 | $9.2M | −$68.2M |
| FY22 | $15.6M | −$68.8M |
| FY21 | $31M | −$34.1M |
| FY20 | $9.2M | −$44.3M |
| FY19 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −6056.4% | −5668.6% |
| FY24 | −1057.1% | −1044.8% |
| FY23 | −823.3% | −744.2% |
| FY22 | −454% | −440.3% |
| FY21 | −110.2% | −110.1% |
| FY20 | −484.2% | −481.4% |
| FY19 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | −$80.2M |
| FY22 | −$75.5M |
| FY21 | −$62M |
| FY20 | −$38.6M |
| FY19 | - |
- ImageneBio
- Healthcare median
Show the numbers
| Year | ImageneBio | Healthcare median |
|---|---|---|
| FY25 | −5668.6% | −30.6% |
| FY24 | −1044.8% | −47% |
| FY23 | −744.2% | −58% |
| FY22 | −440.3% | −80.4% |
| FY21 | −110.1% | −71.9% |
| FY20 | −481.4% | −62.2% |
| FY19 | - | −46.3% |